TSTatiana Valerievna Solomay

Tatiana Valerievna Solomay

*This is an algorithmically generated author record based on publicly available information.

Tatiana Valerievna Solomay has a total of 108 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The significance of the analysis of the incidence of anogenital herpes in assessing the epidemic situation of infection caused by herpes simplex viruses

    by A.N. Kaira, A.A. Murzina, E.V. Romenskaya, T.V. Solomay, A.а. Strogalin

    Infection caused by the herpes simplex virus (HSV) is widespread, but in most countries it is not registered, and research is limited. In the Russian Federation, one form — anogenital herpes virus infection (AG) — is subject to official registration, but data on it are not analysed in an epidemiological context. A retrospective analysis of AG incidence may be relevant for assessing the epidemic patterns of HSV infection. The aim is to evaluate the possibility of using AG incidence data for epidemiological monitoring of HSV infection. A retrospective analysis was conducted of federal statistical observation forms No. 9 and No. 34 for the Mytishchi urban district of the Moscow Region for 2015‑2025. Incidence rates, confidence intervals, and growth / decline rates were calculated; a correlation analysis was performed between the incidence rate and the frequency of detecting HSV DNA using PCR in patients with arterial hypertension. The study showed that the analysis of official statistical data on the incidence of herpes hypertension does not allow us to fully characterize the epidemic process of HSV infection for the following reasons: herpes hypertension is only one of many clinical forms of HSV infection, the remaining forms of HSV infection are not subject to registration and accounting; the established features of the detection and registration of cases HYPERTENSION indicates a marked underestimation of cases among the population of the territory, especially in certain sex, age and social groups; the approaches used to laboratory diagnosis of hypertension require standardization of procedures for the collection, transportation and storage of biological material for PCR studies, as well as species identification and supplementing the examination algorithm with serological methods that detect specific antibodies to HSV 1 and 2 The results obtained indicate the need to develop an integrated approach to assessing the epidemic situation of infection caused by herpes simplex viruses.

  • The role of incidence monitoring in the epidemiological surveillance system for cytomegalovirus infection

    by Solomay T.V. Solomay, Semenenko T.A. Semenenko, Kulikova M.M. Kulikova, Akimkin V.G. Akimkin V, Moscow Region Ooo «Vega-M»

  • Open Access

    Assessing the Effectiveness of Anti-epidemic Measures in a Measles Outbreak

    by O. V. Tsvirkun, N. V. Turaeva, T. V. Solomay, O. B. Sapozhkova

    Relevance. The high contagiousness of measles makes organized groups of children and adults epidemiologically significant due to the ease of aerosol transmission and the risk of persistent secondary transmission. The literature describes various measles outbreaks, varying in duration and number of cases. The evaluation of the anti-epidemic measures implemented in these outbreaks was assessed based on the timeliness of the initiation of anti-epidemic measures, including vaccination of contacts of eligible individuals, the outbreak duration, the ratio of outbreaks with one case to outbreaks with spread of infection, and the number of cases in absolute and relative terms. However, we did not find any studies evaluating the quality of anti-epidemic measures in terms of the magnitude of prevented financial losses and the number of prevented cases. Aims. To evaluate the effectiveness of antiepidemic measures using the example of a measles outbreak among university students. Materials and methods. The materials used for this study included emergency notifications, a report on the investigation of the outbreak with the establishment of a cause-and-effect relationship, «Epidemiological Investigation Cards for Measles Cases and Suspected Cases», and laboratory test results for the presence of IgM and IgG to the measles virus. The study utilized descriptive retrospective epidemiological analysis, serological, and statistical methods. Results. A measles outbreak was recorded in May-June 2024 among 266 dormitory residents. The total number of contacts, including the university, was 502 and was small relative to the total number of students and staff. This was due to the end of academic term and the academic exam period from May 12th to 30th, followed by examinations from June 3rd. Immediately after receiving the emergency notification, an epidemiological investigation was initiated and anti-epidemic measures were implemented. The contact circle and the boundaries of the outbreak were determined. Since the source of infection for the first three simultaneous cases of measles was unclear and all contacts had been vaccinated against measles twice, serological testing was conducted using the ELISA method to detect M antibodies and G anti-measles antibodies. The suspected source of infection was identified among the international students in the dormitory who had not sought medical care. 48 students with questionable G antibody results were vaccinated, and a restrictive measure in the form of distance learning was introduced. Discussion. Although serological testing of contacts is not included in the list of mandatory anti-epidemic measures, given the risk of infection spread, it was conducted. This allowed us to identify not only suspected sources of infection but also individuals who were conditionally seronegative for the measles virus but had been vaccinated against it. This study is the first to use an objective approach to assessing the effectiveness of anti-epidemic measures, expressed in economic terms as the amount of losses prevented. We believe this is very important and promising. Conclusion. The anti-epidemic measures proved effective, limiting the outbreak to 13 days, preventing the infection of 1,822 people, and preventing losses totaling 173,454 rubles.

  • On the state of vaccination of children in the first year of life within the framework of the national calendar of preventive vaccinations

    by A. N. Kaira, A. A. Murzina, T. V. Solomay

    In Russia, as part of the national preventive vaccination calendar (NCPP), children in the first year of life receive vaccinations against tuberculosis, hepatitis B (HBV), diphtheria, tetanus, whooping cough, hemophilic, pneumococcal infection, and polio. According to official statistics, the coverage of vaccinations against the above infections in the country is 95 % or higher, which should ensure the control of morbidity in the population. Nevertheless, in children under one year of age, not only morbidity is recorded, including high rates, but deaths from vaccine-controlled infections are also noted. Non-compliance with the NCPP has been established when vaccinating children under one year of age. The coverage of HBV and tuberculosis vaccinations in the maternity hospital in 2019–2024 was less than 90 % and less than 50 % in the pediatric area against whooping cough, hemophilic infection, HBV. A decrease in the coverage of preventive vaccinations in the maternity hospital during the COVID-19 pandemic has been established. The aim is to evaluate the coverage and timeliness of immunization against hemophilic infection, whooping cough, tuberculosis, and HBV in children under one year of age in 2022–2024 in the maternity hospital and pediatric area, including during the COVID — 19 pandemic. The materials for the study were the official statistical observation forms of the Russian Federation for 2019–2024. The indicators of vaccination coverage at 12 months against whooping cough, HBV (including in the first 24 hours), hemophilic infection and at 30 days against tuberculosis were analyzed. The assessment of the timeliness of immunization of children under the age of 1 year using personalized registration forms and the analysis of the incidence of whooping cough, hemophilic infection, tuberculosis, HBV (0/000) were carried out. Non-compliance with the deadlines for preventive vaccinations established by the NCPP in children under one year of age was revealed. The coverage of vaccinations against HBV and tuberculosis in the maternity hospital in 2019–2024 was less than 90 %, in the pediatric area less than 50 % against whooping cough, hemophilic infection, HBV. The impact of the COVID-19 pandemic on the coverage of newborns with vaccinations in the maternity hospital has been established. A change in the approach to assessing the coverage of preventive vaccinations within the NCPP is required.

  • Assessment of the effect of specific immunoprophylaxis on the epidemic process of Epstein-Barr virus infection

    by T. V. Solomay, T. A. Semenenko, V. G. Akimkin

    Specific immunoprophylaxis of infectious diseases is recognized as one of the most effective ways to influence the epidemic process, reducing morbidity, the number of possible complications and deaths and, as a result, significantly reducing government losses associated with the treatment and withdrawal of such individuals from economic relations. At the present stage, there are no means of specific immunoprophylaxis of Epstein-Barr virus (EBV) infection in the world. At the same time, the availability of information about the main characteristics of the epidemic process of EBV infection already makes it possible to make a long-term forecast, taking into account the use of potential vaccine preparations. Objective: to evaluate the effectiveness of strategies for potential immunoprophylaxis of EBV infection. To make a forecast of the development of the epidemic process of EBV infection in the territory of In Moscow, when conducting specific prophylaxis, information on the results of the IgM VCA, IgG EA, IgG VCA and IgG EBNA examination of persons of different genders and ages who contacted the offices of a commercial laboratory, as well as official statistics on the number of births and deaths in 2017–2021 were used. Four potential vaccination strategies were considered, the first of which included immunization of 1 — year-old children with 10 years of post-vaccination protection, the second — 1‑year-old children and 18–39‑year-old women with 10 years of post-vaccination protection, the third — 1‑year-old children with a lifetime of post-vaccination protection, the fourth — 1‑year old children and 18–39‑year-old women with a lifetime of the duration of post-vaccination protection. The fourth scenario is considered to be the most effective, as it will be characterized by the lowest rates of both primary and chronic EBV infection in all age groups compared with the pre-vaccination period, as well as with the other three described scenarios. An analysis of the forecast scenarios for the development of the epidemic process under different conditions of immunization has shown that when developing a vaccine, the duration of protective protection of which will be 10 years, in order to realize the possibility of managing the epidemic process of EBV infection, additional booster revaccination will eventually be required. With constant maintenance of high vaccination coverage with a drug that provides lifelong immune protection, it is possible to achieve gradual elimination of EBV from the host population. At the same time, at the stage of registration of isolated cases of EBV infection among the population, a review of measures to influence the epidemic process of this infection will be required.

  • Some epidemiological aspects of mycoplasma pneumonia in the Russian Federation

    by A. N. Kaira, A. A. Murzina, T. V. Solomay, M. M. Kulikova, Sergiev Posad Vega-M Llc

    Mycoplasma pneumoniae deserves special attention among the pathogens that cause community-acquired pneumonia. In recent years, there has been an increase in the incidence of mycoplasma pneumonia in Europe and Asia. The aim is to evaluate the main epidemiological features of Mycoplasma pneumonias in the Russian Federation according to form No. 2 «Information on infectious and parasitic diseases» and state reports «On the state of sanitary and epidemiological welfare of the population of the Russian Federation». It has been established that the average long-term incidence of mycoplasma pneumonia in the Russian Federation in 2019– 2023 was 5.7 per 100,000 population of the country. The indicators increased from 7.02 in 2019 to 14.78 per 100,000 population in 2023. The incidence of urban diseases significantly prevailed over that of rural populations. The highest incidence rates occurred in groups of children aged 3–7 and 8–14 years. Significant differences in the incidence of mycoplasma pneumonia in different federal districts of the country have been established. Thus, community-acquired pneumonia caused by Mycoplasma pneumoniae is relevant for domestic healthcare due to the presence of an increase in morbidity, the involvement in the epidemic process of people of different age groups with the highest rates among children aged 3–14 years, the formation of foci of group morbidity, a wide geographical spread and the presence of pronounced errors in the diagnosis and statistical accounting of this nosological form.


  • Open Access

    Databank of genomic sequences of pathogenic microorganisms and its role in the implementation of epidemiological surveillance

    by T. A. Semenenko, V. G. Akimkin, T. V. Solomay

    Despite the fact that databanks of genomic sequences have clear information links with biological samples, they are an independent intellectual resource in demand among many researchers. To deposit information obtained in the course of molecular genetic studies in Russia, the Virus Genome Aggregator of Russia (VGARus) databank was created.Aim. To evaluate data on the variability of genetic sequences of the Epstein-Barr virus (EBV), obtained as a result of Russian studies, and the possibility of their integration into the VGARus database forsubsequent use in epidemiological surveillance.Material and methods. A search for publications was carried out in the PubMed, eLibrary, Cyberleninka databases. In total, the study included 32 papers of Russian and external authors that meet the stated aim. Results. The number of studies containing data on the EBV genetic sequences in the Russian Federation is extremely small. The information presented in publications indicates geographical differences in the ratio of two EBV genotypes, the presence of a special LMP1 TatK gene variant in the Tatars of the Volga region, the difference between Russian EBV samples in the gene encoding the gp350 from those from other world regions. At the same time, information on the genomic sequences obtained in the studies was not deposited in the Russian gene bank in any case.Conclusion. Expanding the potential of the Russian VGARus platform by including information on the genomic sequences of all pathogenic microorganisms circulating in the Russian Federation will require largescale work that takes into account technical features, biological and information security requirements.


  • The role of pathogens of upper respiratory tract viral infections in the formation of an epidemic rise in morbidity in the season 2022–2023 in Moscow

    by Semenenko T.A. Semenenko, Burtseva E.I. Burtseva, Nozdracheva A.V. Nozdracheva, Solomay T.V. Solomay, Ugleva S.V. Ugleva, Gotvyanskaya T.P. Gotvyanskaya, Mukasheva E.A. Mukasheva, Latyshev O.E. Latyshev, Vetrova E.N. Vetrova, Nikitenko N.A. Nikitenko N, et al.


  • Current trends in the development of the epidemic process of community-acquired pneumonia and their relationship with upper respiratory tract infections

    by Linok A.P. Linok, Kulikova M.M. Kulikova, Solomay T.V. Solomay, Linok A.V. Linok, Semenenko A.V. Semenenko, Nikitina G.YU. Nikitina, Sergiev Posad Ooo Vega-M


  • Open Access

    The Economic Burden of Epstein–Barr Virus Infection in the Russian Federation

    by Tatyana V. Solomay, Evgeny M. Voronin, Tatiana A. Semenenko, Ekaterina V. Lavrukhina, Stanislav N. Kuzin, Alexey V. Tutelyan, Vasiliy G. Akimkin

    Introduction: Epstein–Barr virus-related diseases are of great medical and social importance, which requires assessment of economic losses due to costs of medical care and sickness absenteeism. Objective: To propose a methodology for assessing economic damage and to use it for quantification of total damages caused by Epstein–Barr virus (EBV) infections in the Russian Federation in 2022. Materials and methods: The economic damage from EBV infections was determined using official statistics on cases of infectious mononucleosis (2022), upper respiratory tract infections, cardiac arrhythmias, atopic dermatitis, dorsopathy, chronic tonsillitis in the acute phase, cerebrovascular disease, psoriasis, and multisystem inflammatory syndrome associated with COVID-19. Results: Based on the methodology for assessing economic damages described in the article, we found that the total financial losses from EBV-associated diseases in the Russian Federation in 2022 amounted to 1,203.0 billion or 1.2 trillion rubles, which is significantly higher than similar values for all other registered infectious diseases with the exception of COVID-19. COVID-19-related multisystem inflammatory syndrome, upper respiratory tract infections, and cerebrovascular disease account for more than 90 % of all losses. The structure of total costs is dominated by indirect economic losses (1,096.75 billion rubles or 91.2 %) due to sickness absence from work. Conclusion: The findings allow us to outline directions of developing measures to reduce the economic damage from EBV-associated diseases.